Radiopharm Theranostics Limited Sponsored ADR (RADX) Live Share Price, Invest From India

Radiopharm Theranostics Limited Sponsored ADR Stock Performance

as on September 19, 2026 at 2:16 pm IST

Day's High
$1.65
Day's Price Range
$1.84
$1.65
11.52%
Upside
52 Week's Low
52 Week's High
$1.50
52-Week Price Range
$16.25
$1.65
9.09%
Downside
884.85%
Upside

Radiopharm Theranostics Limited Sponsored ADR share price movements today

Previous Close: $1.73
Open: $1.74
Volume: 1.1M
Market Cap: $25.0M
Day's Low - High: $1.65 - $1.84
52 Week Low - High: $1.50 - $16.25

Radiopharm Theranostics Limited Sponsored ADR Historical Returns

1 Month Return: -30.8 %
3 Month Return: -61.12 %
1 Year Return: -73.34 %
3 Year Return: 0 %
5 Year Return: 0 %

Radiopharm Theranostics Limited Sponsored ADR Stock Fundamentals & Key Indicators

Check Radiopharm Theranostics Limited Sponsored ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$25.0M

EPS (TTM)

-1404

Dividend Yield

0.00%

PE Ratio (TTM)

-0.51

Industry PE ratio

-3.09

PEG Ratio

-0.0073906182313261985

Return On Equity TTM

-144.24%

Radiopharm Theranostics Limited Sponsored ADR Stock Valuation

Track how Radiopharm Theranostics Limited Sponsored ADR P/E has moved over time to understand its valuation trends.

Radiopharm Theranostics Limited Sponsored ADR in the last 4 years

Overview
Trends

Lowest (-1.34x)

June 30, 2024

Industry (-3.09x)

June 30, 2025

Today (-1.33x)

June 30, 2025

Highest (-0.71x)

June 30, 2023

LowHigh

Today’s Price to Earnings Ratio: -1.33x

Radiopharm Theranostics Limited Sponsored ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Radiopharm Theranostics Limited Sponsored ADR with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Radiopharm Theranostics Limited Sponsored ADR	NA	$25.0M	NA	-0.51	-39.41%	0.00%
Moderna	BUY	$63.1B	-63.24%	-19.81	-12.57%	0.00%
Vertex Pharmaceuticals	BUY	$130.1B	174.21%	29.81	86.04%	0.00%
Regeneron	BUY	$79.7B	21.1%	18.48	84.86%	0.48%

Stock Returns calculator for Radiopharm Theranostics Limited Sponsored ADR Stock including INR - Dollar returns

The Radiopharm Theranostics Limited Sponsored ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Radiopharm Theranostics Limited Sponsored ADR investment value today

Current value as on today

₹27,605

Returns

-₹72,395

(-72.39%)

Returns from Radiopharm Theranostics Limited Sponsored ADR Stock

-₹74,576 (-74.58%)

Dollar Impact

₹2,182 (+2.18%)

Indian Investors' Interest in Radiopharm Theranostics Limited Sponsored ADR Stock

Search interest for Radiopharm Theranostics Limited Sponsored ADR Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 22, 2026 to September 21, 2026

Change:-54% versus previous 30 day period

Radiopharm Theranostics Limited Sponsored ADR Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2024	Jun 2025
Total Revenue	1	1
Gross Profit	-1	0
Operating Income	-30	-39
EBITDA	-29	-39
Interest Expense	0	0
Depreciation	1	-
Income Before Tax	-32	-29
Income Tax Expense	-4	0
Net Income	-26	-28
Net Profit Margin	-90.30%	11.60%

Radiopharm Theranostics Limited Sponsored ADR Annual Profit & Loss

All numbers in Millions USD

	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	0	0	3	2
Gross Profit	0	0	0	-2
Operating Income	-34	-36	-38	-66
EBITDA	-31	-44	-38	-66
Interest Expense	0	0	0	0
Depreciation	3	3	0	-
Income Before Tax	-34	-47	-38	-55
Income Tax Expense	0	0	0	0
Net Income	-34	-47	-38	-53
Net Profit Margin	100.00%	100.00%	1.08%	-77.67%

Radiopharm Theranostics Limited Sponsored ADR Quarterly Cash Flow

All numbers in Millions USD

	Dec 2024	Jun 2025
Net Income	-26	-28
Operating Cash Flow	-22	-32
Investing Cash Flow	-5	0
Financing Cash Flow	32	2
Change in Cash	5	-29

Radiopharm Theranostics Limited Sponsored ADR Annual Cash Flow

All numbers in Millions USD

	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Net Income	-34	-47	-	-53
Operating Cash Flow	-23	-22	-36	-51
Investing Cash Flow	-1	0	1	-5
Financing Cash Flow	9	30	45	32
Change in Cash	-15	6	10	-23

Global Institutional Holdings in Radiopharm Theranostics Limited Sponsored ADR

Funds	Holdings
PNC Financial Services Group Inc	0.14%
Rhumbline Advisers	0%
Strategic Wealth Partners	0%
Virtu Financial LLC	0%
Marex Group Ltd	0%

See all

Insights on Radiopharm Theranostics Limited Sponsored ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 584.9%
NEGATIVE IMPACT
Price Dip
In the last 7 days, RADX stock has moved down by -16.7%

About Radiopharm Theranostics Limited Sponsored ADR

Radiopharm Theranostics Limited, an Australian company established in Carlton in 2021, specializes in the research and development of cutting-edge radiopharmaceutical treatments. Their mission is to address critical gaps in healthcare by creating products for both diagnostic imaging and therapeutic intervention across a spectrum of challenging medical conditions. The company's diverse pipeline features: RAD 204, designed to target PD-L1 for non-small cell lung cancer; RAD 202, aimed at HER2 for breast cancer and other solid tumor types; and two avß6 integrin-targeting agents, RAD 301 (a diagnostic tool for pancreatic ductal adenocarcinoma) and RAD 302 (a therapeutic agent for various cancers). Other significant developments include RAD 101 and RAD 102 for brain metastases, RAD 402 for advanced prostate cancer, and RV01 for multiple solid tumors. To accelerate the clinical progression of its radiopharmaceutical assets, Radiopharm Theranostics maintains a strategic partnership with Lantheus Holdings, Inc.

Organisation	Radiopharm Theranostics Limited Sponsored ADR
Headquarters	62 Lygon Street, Carlton, VIC, 3053, AU
Industry	Biotechnology
CEO	Riccardo Canevari
E-voting on shares	Click here to vote

Key Management of Radiopharm Theranostics Limited Sponsored ADR

Name	Title
Dr. Dimitris Voliotis M.D.	Chief Medical Officer
Mr. Aaron Laurita	Chief Financial Officer
Mr. Hitesh Goel	Head of Project Management
Mr. Nathan Jong C.A.	Joint Company Secretary
Ms. Amritha Sushil	Joint Company Secretary
Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD	Founder & Executive Chairman
Mr. Riccardo Canevari	MD, CEO & Director

FAQs

What is Radiopharm Theranostics Limited Sponsored ADR share price today?

Radiopharm Theranostics Limited Sponsored ADR share price today is $1.65 as on September 19, 2026 at 8:46 am IST at the close of the market. Radiopharm Theranostics Limited Sponsored ADR share today touched a day high of $1.84 and a low of $1.65.

What is the 52 week high and 52 week low for Radiopharm Theranostics Limited Sponsored ADR share?

Radiopharm Theranostics Limited Sponsored ADR share touched a 52 week high of $16.25 on January 1, 1970 and a 52 week low of $1.50 on January 1, 1970. Radiopharm Theranostics Limited Sponsored ADR stock price today i.e. September 19, 2026 at 8:46 am IST is closed at $1.65,which is 89.85% down from its 52 week high and 10.00% up from its 52 week low.

What is Radiopharm Theranostics Limited Sponsored ADR's market capitalisation today?

Radiopharm Theranostics Limited Sponsored ADR market capitalisation is $0.00T as on September 19, 2026 at 8:46 am IST.

How to invest in Radiopharm Theranostics Limited Sponsored ADR Stock (RADX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Radiopharm Theranostics Limited Sponsored ADR on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Radiopharm Theranostics Limited Sponsored ADR Shares that will get you 0.9091 shares as per Radiopharm Theranostics Limited Sponsored ADR share price of $1.65 per share as on September 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Radiopharm Theranostics Limited Sponsored ADR Stock (RADX) from India?

Indian investors can start investing in Radiopharm Theranostics Limited Sponsored ADR (RADX) shares with as little as ₹95.88 or $1 (as of September 21, 2026 at 12:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Radiopharm Theranostics Limited Sponsored ADR stock (as per the Rupee-Dollar exchange rate as on September 21, 2026 at 12:39 am IST). Based on Radiopharm Theranostics Limited Sponsored ADR share’s latest price of $1.65 as on September 19, 2026 at 8:46 am IST, you will get 6.0606 shares of Radiopharm Theranostics Limited Sponsored ADR. Learn more about fractional shares .